Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's disease.

Autor: Kim, Jae-Bong1,2,3 (AUTHOR), Kim, Yujeong4 (AUTHOR), Kim, Soo-Jeong2 (AUTHOR), Ha, Tae‑Young1,2,5 (AUTHOR), Kim, Dong-Kyu2 (AUTHOR), Kim, Dong Won4 (AUTHOR), So, Minyoung6 (AUTHOR), Kim, Seung Ho2,7 (AUTHOR), Woo, Hyun Goo2,7 (AUTHOR), Yoon, Dukyong4 (AUTHOR) dukyong.yoon@yonsei.ac.kr, Park, Sang Myun1,2,3 (AUTHOR) sangmyun@ajou.ac.kr
Zdroj: Journal of Neuroinflammation. 2/21/2024, Vol. 21 Issue 1, p1-18. 18p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje